All Stories

  1. The Greater the Number of Altered Eating Behaviors in Obesity, the More Severe the Psychopathology
  2. The Association Between Antipsychotics and Bone Fragility: An Updated Comprehensive Review
  3. Editorial: Biological and non-pharmacological treatments of obsessive-compulsive disorder and related disorders
  4. Latent profile analysis identifies four different clinical schizophrenia profiles through aberrant salience
  5. Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophrenia
  6. Applying a clinical staging model in patients affected by schizophrenia spectrum disorder
  7. Metacognition as a transdiagnostic factor across eating disorders: a latent profile analysis study
  8. The European psychiatric association (EPA) – early career psychiatrists committee survey on trainees’ and early-career psychiatrists’ attitudes towards therapeutic drug monitoring (TDM) use and utility during antipsychotic treatment
  9. Immunomodulatory Effects of Clozapine: More Than Just a Side Effect in Schizophrenia
  10. Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database
  11. Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial
  12. Obsessive–Compulsive Disorder as an Epiphenomenon of Comorbid Bipolar Disorder? An Updated Systematic Review
  13. The role of arts in moderating mental health-related stigma: views of early career psychiatrists and trainees from different parts of the world
  14. Influence of NUCB/Nesfatin-1 Polymorphism on Treatment Response to Naltrexone/Bupropion SR in Binge Eating Disorder and Obesity
  15. Stigma toward substance use disorders: a multinational perspective and call for action
  16. Using latent class analysis to identify different clinical profiles according to food addiction symptoms in obesity with and without binge eating disorder
  17. Variations in obsessive compulsive disorder symptomatology across cultural dimensions
  18. Impact of stigma on the placement of mental health facilities: insights from early career psychiatrists worldwide
  19. Parity of esteem: A global COVID-19 vaccination approach for people with mental illnesses, based on facts from 34 countries; recommendations and solutions
  20. Editorial: Safety and side effects of psychotropic medications, volume II
  21. Mental illness stigma among perinatal women in low- and middle-income countries: early career psychiatrists' perspective
  22. Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
  23. Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel
  24. Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database
  25. The relationship of food addiction with binge eating disorder and obesity: A network analysis study
  26. Head Regional Differences in Thermal Comfort: Evaluating a Novel Surgical Helmet Cooling Method with Phase Change Material
  27. Reactive hypoglycemia in binge eating disorder, food addiction, and the comorbid phenotype: unravelling the metabolic drive to disordered eating behaviours
  28. An update from the WPA Working Group on Digitalization in Mental Health and Care
  29. Pain experience in eating disorders: The mediating role of depression, alexithymia and interoceptive awareness
  30. Cognitive biases are associated with aberrant salience experience in schizophrenia spectrum disorders
  31. Defining the minimum clinically important difference (MCID) in the hospital anxiety and depression scale (HADS) in patients undergoing total hip and knee arthroplasty
  32. Collaborative research on mental health in the post-COVID-19 era: an early career psychiatrists' perspective
  33. Esketamine nasal spray in severe bipolar depression with borderline personality disorder and history of multiple substance abuse: A case report
  34. Sleep Disturbances in Panic Disorder with Comorbid Complex PTSD: A Possible Relationship and Different Psychopathology?
  35. Editorial: Community series in mental illness, culture, and society: dealing with the COVID-19 pandemic, volume VII
  36. Systemic Racism, Ethnic Discrimination, and Children’s Mental Health: Fostering Global Conversations
  37. Editorial: Community series in mental illness, culture, and society: dealing with the COVID-19 pandemic, volume VI
  38. Editorial: Community series in mental illness, culture, and society: dealing with the COVID-19 pandemic: volume V
  39. Editorial: Mental health and internalized stigma in people with severe mental illness
  40. Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database
  41. Effectiveness of SGA-LAIs on Clinical, Cognitive, and Social Domains in Schizophrenia: Results from a Prospective Naturalistic Study
  42. Editorial: Community series in mental illness, culture, and society: Dealing with the COVID-19 pandemic - Volume IV
  43. Sleep Disturbances in Generalized Anxiety Disorder: The Role of Calcium Homeostasis Imbalance
  44. Postoperative psychological factors and quality of life but not shoulder brace adherence affect clinical outcomes after arthroscopic rotator cuff repair
  45. Editorial: Safety and side effects of psychotropic medications
  46. Editorial: Community series in mental illness, culture, and society: Dealing with the COVID-19 pandemic - Volume III
  47. Mental health-related stigma in movies: A call for action to the cinema industry
  48. Editorial: Mental-health-related stigma and discrimination: Prevention, role, and management strategies
  49. Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
  50. Editorial: Community series in mental illness, culture, and society: Dealing with the COVID-19 pandemic—Volume II
  51. Editorial: Mental illness, culture, and society: Dealing with the COVID-19 pandemic
  52. The use of antidepressants is linked to bone loss: A systematic review and metanalysis
  53. The Mediation Effect of Peripheral Biomarkers of Calcium Metabolism and Chronotypes in Bipolar Disorder Psychopathology
  54. Brain stimulation and other biological non-pharmacological interventions in mental disorders: An umbrella review
  55. Validation of a novel Psychosis-Implicit Association Test (P-IAT) as a diagnostic support tool
  56. Is everyone invited to the discussion table? A Bibliometric Analysis COVID-19 Related Mental Health Literature
  57. Internalized-stigma and dissociative experiences in bipolar disorder
  58. Aberrant salience correlates with psychotic dimensions in outpatients with schizophrenia spectrum disorders
  59. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases
  60. 10th EPA Summer School on Research 2021: sharing experience of the first online edition
  61. THE RISING SCOURGE OF MENTAL ILLNESS AND INFODEMIC: AN OUTCOME OF SOCIAL MEDIA AND COVID-19
  62. EFFECTS OF THE GLOBAL ECOLOGICAL CRISIS ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS: AN INTERNATIONAL PERSPECTIVE
  63. The grief experience during the COVID-19 pandemic across different cultures
  64. Two Cases of Olfactory Reference Syndrome Treated with Risperidone
  65. Associations of lockdown stringency and duration with Google searches for mental health terms during the COVID-19 pandemic: A nine-country study
  66. Depression and anxiety among Pakistani healthcare workers amid COVID-19 pandemic: A qualitative study
  67. Nicotine replacement gums dependence: A case report of a new potential addiction
  68. Palatal myoclonus with tinnitus treated as a psychogenic disorder for 35-years
  69. Primary Obsessive Slowness: A Complex Presentation and Treatment Difficulties
  70. Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis
  71. Pharmacovigilance approaches to study rare and very rare side-effects: the example of clozapine-related DiHS/DRESS syndrome
  72. Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis
  73. Support the frontliners – good initiatives during the COVID-19 pandemic for healthcare workers across the world: is this what we really need?
  74. Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond
  75. Development, validation and clinical use of the Eating Behaviors Assessment for Obesity (EBA-O)
  76. Nutrition and Depression
  77. The Mental Health of Caregivers and Their Patients With Dementia During the COVID-19 Pandemic: A Systematic Review
  78. Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease
  79. How to overcome barriers to publication in low‐ and middle‐income countries: Recommendations from early career psychiatrists and researchers from around the world
  80. How is the COVID-19 pandemic affecting women's menstrual cycles and quality of life? A view from South Asia
  81. Awareness of illness moderates self-assessment of psychotic symptoms
  82. Prevalence of impaired kidney function in patients with long‐term lithium‐treatment: a systematic review and meta‐analysis
  83. Dissociative Symptoms in Bipolar Disorder: Impact on Clinical Course and Treatment Response
  84. Olanzapine-Related Somnambulism
  85. La représentation des femmes dans les comités éditoriaux des revues de psychiatrie : multiples défis et obstacles
  86. Fear During COVID-19 pandemic: Fear of COVID-19 Scale Measurement Properties
  87. Mental status via telepsychiatry: The potential pitfalls
  88. Suicidal behavior sociocultural factors in developing countries during COVID-19
  89. Role of Social Media in Psychiatry During Pandemic
  90. A systematic review and pooled, patient‐level analysis of predictors of mortality in neuroleptic malignant syndrome
  91. Impact of videoconferencing applications on mental health
  92. Core clinical manifestations of clozapine-related DRESS syndrome: A network analysis
  93. Executive functions and depressive symptoms interplay in binge eating disorder: A structural equation model analysis
  94. Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile
  95. Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis
  96. Suicide is multifactorial: There should be a difference between a news report and a scientific report of suicide
  97. Coronavirus outbreak from early career psychiatrists' viewpoint: What we have learned so far
  98. Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review
  99. Challenges and Opportunities of Psychiatric Training During COVID-19: Early Career Psychiatrists’ Perspective Across the World
  100. Current and emerging long-acting antipsychotics for the treatment of schizophrenia
  101. Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression
  102. Internet and Pornography Use During the COVID-19 Pandemic: Presumed Impact and What Can Be Done
  103. COVID-19 & psychiatric care: Need of a plan to prevent follow-up discontinuation
  104. Antisocial Personality Disorder in Bipolar Disorder: A Systematic Review
  105. Clinical Impact of Psychopathy on Bipolar Disorder
  106. Telepsychiatry in Low- and Middle-Income Countries During COVID-19
  107. Matrix Metalloproteinase 9 Blood Alterations in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis
  108. Current state of cannabis use, policies, and research across sixteen countries: Cross-Country Comparisons and International perspectives
  109. 24-hour mobile phone helpline service for women discharged from mother-baby psychiatry unit (MBU): Is it possible?
  110. IMPACT OF BIPOLAR DISORDER AND OBSESSIVE-COMPULSIVE DISORDER COMORBIDITY ON NEUROCOGNITIVE PROFILE: A MINI-REVIEW
  111. It’s COVID o’clock—time to publish or perish
  112. Development and Validation of a Computerized Adaptive Assessment Tool for Discrimination and Measurement of Psychotic Symptoms
  113. Effect of COVID-19 on Mental Health Rehabilitation Centers
  114. Infectious disease outbreak related stigma and discrimination during the COVID-19 pandemic: Drivers, facilitators, manifestations, and outcomes across the world
  115. Management of psychiatric conditions and delirium during the COVID-19 pandemic across continents: The lessons thus far
  116. Pathways to orthorexia nervosa: a case series discussion
  117. The urge to implement and expand telepsychiatry during the COVID-19 crisis: Early career psychiatrists’ perspective
  118. Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review
  119. Application of Support Vector Machine on fMRI Data as Biomarkers in Schizophrenia Diagnosis: A Systematic Review
  120. La urgencia de implementar y ampliar la telepsiquiatría durante la crisis de COVID-19: perspectiva de los psiquiatras que inician su carrera
  121. An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder
  122. Second-generation long-acting injections anti-psychotics improve executive functions in patients with schizophrenia: a 12-month real-world study
  123. Sleep Disturbance in Bipolar Disorder: Neuroglia and Circadian Rhythms
  124. ‘Impaired Autonomy and Performance’ predicts binge eating disorder among obese patients
  125. Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review
  126. Weight and age do not account for a worse executive functioning among BED-obese patients
  127. Effectiveness of integrated psychological therapy on clinical, neuropsychological, emotional and functional outcome in schizophrenia: a RCT study
  128. Bipolar disorder and obsessive compulsive disorder: The comorbidity does not further impair the neurocognitive profile